Topics

About Raman Imaging Group

One of our main research areas is development of spectroscopic methodology for the diagnosis of lifestyle diseases (atherosclerosis, diabetes, hypertension, cancer metastasis, hepatic steatosis, heart failure and aortic stenosis), determination of spectroscopic markers of chemical changes due to pathologies and investigation of cardioprotective drugs.

Another important research topic is investigation of mechanisms of cellular processes in vitro and in vivo, for example cellular responses on inflammatory factors, oxidative stress, investigation of interactions of cells with chemotherapeutics, studies on cell uptake and processes of lipid droplet formation.

The group also conducts research on multi-parameter imaging of tissues and cells, systems with supramolecular chirality and chirality induction phenomena, designing SERS nanosensors for detecting markers of lifestyle diseases, spectroscopic identification of degradation products of painting layers, distribution studies and polymorphism of active substances, analysis of minerals and meteorites.

Currently, the group conducts research within twenty five scientific projects, including the MSCA-ITN-ETN project under the Horizon 2020 and various national programs (NCN, NCBiR, MNiSW). The publishing output of the team since it was created (2009) is about 200 scientific papers in scientific journals and book chapters. The group participates in national and international scientific networks, e.g. the Polish Chemical Society, CLIRSPEC (https://clirspec.org/), the COST Raman4Clinics action.

Raman Imaging Group performs spectroscopic measurements to order (please, contact witch: m.baranska@uj.edu.pl).

CLIRSPEC – the International Society for Clinical Spectroscopy (https://clirspec.org/), whose director is Malgosia, is a non-profit organisation, constituted in 2015. The Society exists to act as a platform for those individuals, teams and organisations wishing to promote the translation of spectroscopy into the clinical environment, for the general benefit of patients; for example, to improve patient diagnosis and prognosis.

 

Read more…

By Raman

Recent Posts

Unlocking Precision in Dermatology Trials: The Impact of Optical Coherence Tomography for CROs

In the dynamic landscape of dermatology research and development, Clinical Research Organizations (CROs) play a…

Testing trends Webinar – Discover all the news around the evaluation at NYSCC

Explore Trends and Innovations at NYSCC To register, click here   📅 on Tuesday May…

Roger Guillemin: Neuroscientist who Showed How the Brain Controls Hormones via Nature

Roger Guillemin identified the molecules in the brain that control the production of hormones in…